Recent Finacing
Recent Raise
Novome develops engineered commensal bacteria (GEMMs) that colonize the gut, secrete therapeutic proteins with controllable abundance via prebiotic dosing, and advance oral live biotherapeutics for hyperoxaluria.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Novome Biotechnologies.
